Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma
Background and objective: Lenvatinib showed promising results in a subgroup of patients with poorly differentiated thyroid carcinoma (PDTC) in the SELEC T trial. Our aim was to report the effectiveness and tolerability of lenvatinib in our s eries of PDTC patients. Methods: Medical records of eigh...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2023-04-01
|
| Series: | European Thyroid Journal |
| Subjects: | |
| Online Access: | https://etj.bioscientifica.com/view/journals/etj/12/2/ETJ-23-0003.xml |